October 17, 2011
Lazanda Nasal Spray Available for Breakthrough Cancer Pain
Lazanda is a Schedule II controlled substance and is available through a Risk Evaluation and Mitigation Strategy (REMS) program. Under the Lazanda REMS program, pharmacies, distributors, and health care professionals who prescribe to outpatients are required to enroll in the program to dispense, distribute, and prescribe Lazanda.
For more information call (866) 435-6775 or visit www.lazanda.com.